Mental Health Center and Psychiatric Laboratory, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China.
Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Psychol Med. 2023 Jun;53(8):3500-3510. doi: 10.1017/S0033291722000058. Epub 2022 Feb 15.
Grey matter (GM) reduction is a consistent observation in established late stages of schizophrenia, but patients in the untreated early stages of illness display an increase as well as a decrease in GM distribution relative to healthy controls (HC). The relative excess of GM may indicate putative compensatory responses, though to date its relevance is unclear.
343 first-episode treatment-naïve patients with schizophrenia (FES) and 342 HC were recruited. Multivariate source-based morphometry was performed to identify covarying 'networks' of grey matter concentration (GMC). Neurocognitive scores using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and symptom burden using the Positive and Negative Symptoms Scale (PANSS) were obtained. Bivariate linear relationships between GMC and cognition/symptoms were studied.
Compared to healthy subjects, FES had prominently lower GMC in two components; the first consists of the anterior insula, inferior frontal gyrus, anterior cingulate and the second component with the superior temporal gyrus, precuneus, inferior/superior parietal lobule, cuneus, and lingual gyrus. Higher GMC was seen in adjacent areas of the middle and superior temporal gyrus, middle frontal gyrus, inferior parietal cortex and putamen. Greater GMC of this component was associated with lower duration of untreated psychosis, less severe positive symptoms and better performance on cognitive tests.
In untreated stages of schizophrenia, both a distributed lower and higher GMC is observable. While the higher GMC is relatively modest, it occurs across frontoparietal, temporal and subcortical regions in association with reduced illness burden suggesting a compensatory role for higher GMC in the early stages of schizophrenia.
灰质(GM)减少是精神分裂症晚期的一个一致观察结果,但未经治疗的疾病早期阶段的患者与健康对照组(HC)相比,GM 分布既有增加也有减少。相对多余的 GM 可能表明存在潜在的代偿反应,尽管迄今为止其相关性尚不清楚。
招募了 343 名首发未经治疗的精神分裂症患者(FES)和 342 名健康对照者。采用多元源形态计量学方法识别共变的灰质浓度(GMC)“网络”。使用剑桥神经心理学测试自动化电池(CANTAB)获得神经认知评分,使用阳性和阴性症状量表(PANSS)获得症状负担。研究了 GMC 与认知/症状之间的双变量线性关系。
与健康受试者相比,FES 在前脑岛、下额回、前扣带回和上颞叶、楔前叶、下/上顶叶、楔叶和舌回两个成分中表现出明显较低的 GMC。在中颞叶、中额回、下顶叶皮质和壳核的相邻区域观察到更高的 GMC。该成分的 GMC 越高,未治疗的精神病持续时间越短,阳性症状越轻,认知测试的表现越好。
在未经治疗的精神分裂症阶段,可观察到分布广泛的低 GM 和高 GM。虽然高 GM 相对较小,但它发生在前额顶叶、颞叶和皮质下区域,与疾病负担减轻相关,表明高 GM 在精神分裂症的早期阶段具有代偿作用。